ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,528, issued on Aug. 12, was assigned to The General Hospital Corp. (Boston).
"Cromolyn esters and uses thereof" was invented by David R. Elmaleh (Newton, Mass.) and Timothy M. Shoup (Franklin, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds and methods of treating or imaging a disease or disorder, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, ischemic stroke, and prion disease, comprising administering a therapeutically effective amount of a cromolyn ester."
The patent was filed on Dec. 10, 2019, under Application No. 17/312,810.
*For further information, including images, charts and ta...